Back
AtriCure Vs. Perspective Therapeutics Industry Stock Comparison
Sell
34
ATRC
AtriCure
Last Price:
42.26
Seasonality Move:
10.94%
Sell
25
CATX
Perspective Therapeutics
Last Price:
0.27
Seasonality Move:
-9.02%
Sell
34
AtriCure (ATRC)
is a Sell
Is AtriCure a Buy, Sell or Hold?
- The current AtriCure [ATRC] share price is $43.33. The Score for ATRC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ATRC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $0.27. The Score for CATX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $0.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.
ATRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.14 | Sell |
Relative Strength Index (14 RSI): | 43.91 | Sell |
Chaikin Money Flow: | 219236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.25 - 45.29) | Sell |
Bollinger Bands (100): | (44.56 - 52.42) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 35.34 | Sell |
Chaikin Money Flow: | -3321 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.28 - 0.4) | Sell |
Bollinger Bands (100): | (0.38 - 0.64) | Sell |
ATRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.61 | Buy |
20-day SMA: | 43.22 | Buy |
50-day SMA: | 47.9 | Sell |
200-day SMA: | 45.34 | Sell |
8-day EMA: | 43.11 | Buy |
20-day EMA: | 43.76 | Sell |
50-day EMA: | 46.01 | Sell |
200-day EMA: | 46.65 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Sell |
20-day SMA: | 0.32 | Sell |
50-day SMA: | 0.42 | Sell |
200-day SMA: | 0.48 | Sell |
8-day EMA: | 0.28 | Sell |
20-day EMA: | 0.32 | Sell |
50-day EMA: | 0.4 | Sell |
200-day EMA: | 0.47 | Sell |
AtriCure Earnings Growth & ATRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.08 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AtriCure Technical Analysis
Sep 19 | Sep 20 | Sep 21 | Sep 22 | Sep 25 | Sep 26 | Sep 27 | Sep 28 | Sep 29 | Oct 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Sep 19 | Sep 20 | Sep 21 | Sep 22 | Sep 25 | Sep 26 | Sep 27 | Sep 28 | Sep 29 | Oct 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |